top


Board Management

XOventure has developed best practice principles for building and running boards more efficiently to the benefit of CEO and investors. 

“Each of the board of directors is expected to have general as well as specific knowledge that are suprior to the CEO, in order to coach and direct company management. However, the talents on the board are often mismanaged, and the individual board members hang around the table without giving their best”. The efficiency of the board is thus a reflection of the company. A high performing CEO needs coaching and direction of the board to be able to perform even better.

 

Most of our senior XOventure team members have board experience from life science companies (as chariman and/or board members) and are available for additional positions or assisting in forming a well functioning board.

 

 

5 XOventure Board Recommendations:


  1. The CEO is an operational manager and is not member of the board. We all need to report to someone.
  2. The CEO is never recruited from the board, since no board member should have the wrong motives to stab the CEO.
  3. The board shall self assess individual performance anually and make adjustments.
  4. All fees and other board incentives are publicly available (this also goes also for Management)
  5. Each board member should have a focus area and a meeting before each board meeting with the relevant manager e.g. CFO. This converts the board from a passive advisory "organ" to an active group that can support or challenge issues based on first hand information.

 

Last Updated on Thursday, 15 September 2011 13:11
 

News

COURSE
Drug Development:
Challenges & Solutions
May 23-25, 2011, Copenhagen
Pathology Experts
in collaboration with XOventure
More information
_____________
XOventure opens
new Copenhagen office:
Bagsværdvej 70A
DK-2800 Lyngby
Opening Reception
Feb 4, 2011
_____________
Managing Partner
Jørgen Thorball
receives Medicon Valley
Cross-Border Award
Oct 28, 2010
ReadXOventure GmbH established in Lucerne, central Switzerland!

 

Dec 2011:
2nd Drug Development Course

Registration open!
Pathology Experts & XOventure.
More Information 


Nov 2011: 
Entrepreneur of the Year

Immudex, a management buy-out from Dako led by XO win Ernst & Young's "Entrepreneur of the Year" 2011!


July 2011: XOventure GmbH 
XOventure GmbH established in Lucerne, central Switzerland!   


May 2011:
Success with course!
 
 
Drug Development: 
Challenges & Solutions 
Pathology Experts & XOventure.



bottom

Powered by Joomla!. Designed by: Joomla 1.5 Template, web space. Valid XHTML and CSS.